+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Global Pen Needles Market Report and Forecast 2023-2031

  • PDF Icon


  • 140 Pages
  • May 2023
  • Region: Global
  • Expert Market Research
  • ID: 5797832
The global pen needles market size attained a value of USD 3.1 billion in 2022. The market is likely to grow further at a CAGR of 13.90% during the forecast period of 2023-2031 to attain a value of USD 10.05 billion by 2031.

Pen Needles Market: Introduction

Pen needles are a key component of injection devices used for the delivery of various drugs across several medical applications. They are used in conjunction with injection pens to deliver injectable medications into the body. A pen needle consists of a hollow needle which is embedded in a plastic hub and attaches to injection pens.

Pen needles are most commonly used by people with diabetes who often need multiple daily insulin injections. The use of pen needles and insulin pens has grown in popularity due to their ease of use, convenience, and the lessened pain compared to traditional insulin syringes. They are available in different lengths and diameters to accommodate various user needs.

Apart from diabetes management, pen needles are also used in therapies that require multiple injections, such as fertility treatments, growth hormone therapy, and osteoporosis management. They are preferred for their precision, which helps to ensure that medication is delivered accurately, thereby improving treatment efficacy.

The growing prevalence of chronic diseases worldwide that require frequent drug administration has been a key driver in the demand for pen needles. Furthermore, advancements in technology have led to the development of pen needles with finer and shorter needles, further enhancing patient comfort and preference for these devices.

Pen Needles Market Segmentations

The market can be categorised into product type, needle length, usability, therapy, application, end user, and region.

Market Breakup by Product Type

  • Standard Pen Needles
  • Safety Pen Needles

Market Breakup by Needles Length

  • 4mm
  • 5mm
  • 6mm
  • 8mm
  • 10mm
  • 12mm

Market Breakup by Usability

  • Reusable Pen Needles
  • Disposable Pen Needles

Market Breakup by Therapy

  • Insulin
  • Glucagon-like-Peptide-1 (GLP-1)
  • Growth Hormone

Market Breakup by Application

  • Diabetes
  • Growth Hormone Deficiency
  • Others

Global Pen Needles Market Breakup by End User

  • Hospitals
  • Clinics
  • Over The Counter
  • Home Healthcare
  • Others

Pen Needles Market Breakup by Region

North America

  • United States of America
  • Canada


  • United Kingdom
  • Germany
  • France
  • Italy
  • Others

Asia Pacific

  • China
  • Japan
  • India
  • Australia
  • Others

Latin America

  • Brazil
  • Argentina
  • Mexico
  • Others

Middle East and Africa

  • Saudi Arabia
  • United Arab Emirates
  • Nigeria
  • South Africa
  • Others

Pen Needles Market Scenario

The global pen needles market is currently on a robust growth trajectory, fuelled primarily by the escalating prevalence of chronic diseases such as diabetes, which necessitate regular, often multiple daily, injections for their management. According to the International Diabetes Federation, over 460 million people worldwide are living with diabetes, a number projected to reach 700 million by 2045. Given this increasing patient population, the demand for pen needles is set to rise correspondingly.

In terms of product innovation, there has been a shift towards shorter, thinner pen needles to minimize pain and the risk of injecting into the muscle instead of subcutaneous fat. The advent of technologies such as safety pen needles and pen needles with built-in removal features to prevent accidental needlestick injuries are also boosting the market growth.

Moreover, the growing adoption of self-injection practices, especially in home care settings, is contributing significantly to the market expansion. This is attributed to the convenience and ease-of-use of pen needles, which empower patients to manage their treatment regimes more effectively.

Regionally, North America currently dominates the global pen needles market, largely due to the high prevalence of diabetes, a well-established healthcare infrastructure, and the presence of key manufacturers in the region. Europe follows closely behind, while the Asia Pacific region is expected to exhibit the fastest growth rate due to a large patient population, improving healthcare facilities, and rising awareness about diabetes management.

On the flip side, factors such as needle anxiety, lack of awareness in low-income countries, and the cost associated with pen needles might restrain the market growth to some extent. However, governmental and non-governmental initiatives to raise awareness about diabetes management, along with manufacturers' efforts to produce more affordable and user-friendly pen needles, are expected to mitigate these challenges.

Overall, the pen needles market is set to continue its growth in the coming years. This growth is underpinned by the increasing prevalence of chronic diseases requiring self-injection, technological advancements in pen needles, and the growing trend of home healthcare.

Key Players in the Global Pen Needles Market

The report gives an in-depth analysis of the key players involved in the pen needles market, sponsors manufacturing the drugs, and putting them through trials to get FDA approvals. The companies included in the market are as follows:
  • Novo Nordisk A/S
  • B. Braun Melsungen AG
  • Terumo Corporation
  • BD
  • Owen Mumford Inc
  • UltiMed, Inc
  • Artsana S.p.A
  • Trividia Health, Inc
  • STAT Medical Devices
  • Simple Diagnostics
  • Pietrasanta Pharma SpA
  • Henso Medical (Hangzhou) Co., Ltd
  • Shanghai Beipu Medical Co., Ltd
  • Zhejiang Kindly Medical Devices Co., Ltd
  • ARKRAY, Inc
  • AstraZeneca
  • GlaxoSmithKline plc

Table of Contents

1 Preface
1.1 Objectives of the Study
1.2 Key Assumptions
1.3 Report Coverage - Key Segmentation and Scope
1.4 Research Methodology
2 Executive Summary
3 Global Pen Needles Market Overview
3.1 Global Pen Needles Market Historical Value (2016-2022)
3.2 Global Pen Needles Market Forecast Value (2023-2031)
4 Global Pen Needles Market Landscape
4.1 Global Pen Needles Developers Landscape
4.1.1 Analysis by Year of Establishment
4.1.2 Analysis by Company Size
4.1.3 Analysis by Region
4.2 Global Pen Needles Product Landscape
4.2.1 Analysis by Product Type
4.2.2 Analysis by Applications
4.2.3 Analysis by End User
5 Global Pen Needles Market Dynamics
5.1 Market Drivers and Constraints
5.2 SWOT Analysis
5.3 Porter’s Five Forces Model
5.4 Key Demand Indicators
5.5 Key Price Indicators
5.6 Industry Events, Initiatives, and Trends
5.7 Value Chain Analysis
6 Global Pen Needles Market Segmentation
6.1 Global Pen Needles Market by Product Type
6.1.1 Market Overview
6.1.2 Standard Pen Needles
6.1.3 Safety Pen Needles
6.2 Global Pen Needles Market by Needles Length
6.2.1 Market Overview
6.2.2 4mm
6.2.3 5mm
6.2.4 6mm
6.2.5 8mm
6.2.6 10mm
6.2.7 12mm
6.3 Global Pen Needles Market by Usability
6.3.1 Market Overview
6.3.2 Reusable Pen Needles
6.3.3 Disposable Pen Needles
6.4 Global Pen Needles Market by Therapy
6.4.1 Market Overview
6.4.2 Insulin
6.4.3 Glucagon-like-Peptide-1 (GLP-1)
6.4.4 Growth Hormone
6.5 Global Pen Needles Market by Application
6.5.1 Market Overview
6.5.2 Diabetes
6.5.3 Growth Hormone Deficiency
6.5.4 Others
6.6 Global Pen Needles Market by End User
6.6.1 Market Overview
6.6.2 Hospitals
6.6.3 Clinics
6.6.4 Over The Counter
6.6.5 Home Healthcare
6.6.6 Others
6.7 Global Pen Needles Market by Region
6.7.1 Market Overview
6.7.2 North America
6.7.3 Europe
6.7.4 Asia Pacific
6.7.5 Latin America
6.7.6 Middle East and Africa
7 North America Pen Needles Market
7.1 Market Share by Country
7.2 United States of America
7.3 Canada
8 Europe Pen Needles Market
8.1 Market Share by Country
8.2 United Kingdom
8.3 Germany
8.4 France
8.5 Italy
8.6 Others
9 Asia Pacific Pen Needles Market
9.1 Market Share by Country
9.2 China
9.3 Japan
9.4 India
9.6 Australia
9.7 Others
10 Latin America Pen Needles Market
10.1 Market Share by Country
10.2 Brazil
10.3 Argentina
10.4 Mexico
10.5 Others
11 Middle East and Africa Pen Needles Market
11.1 Market Share by Country
11.2 Saudi Arabia
11.3 United Arab Emirates
11.4 Nigeria
11.5 South Africa
11.6 Others
12 Patent Analysis
12.1 Analysis by Type of Patent
12.2 Analysis by Publication year
12.3 Analysis by Issuing Authority
12.4 Analysis by Patent Age
12.5 Analysis by CPC Analysis
12.6 Analysis by Patent Valuation
12.7 Analysis by Key Players
13 Grants Analysis
13.1 Analysis by year
13.2 Analysis by Amount Awarded
13.3 Analysis by Issuing Authority
13.4 Analysis by Grant Application
13.5 Analysis by Funding Institute
13.6 Analysis by NIH Departments
13.7 Analysis by Recipient Organization
14 Funding Analysis
14.1 Analysis by Funding Instances
14.2 Analysis by Type of Funding
14.3 Analysis by Funding Amount
14.4 Analysis by Leading Players
14.5 Analysis by Leading Investors
14.6 Analysis by Geography
15 Partnership and Collaborations Analysis
15.1 Analysis by Partnership Instances
15.2 Analysis by Type of Partnership
15.3 Analysis by Leading Players
15.4 Analysis by Geography
16 Regulatory Framework
16.1 Regulatory Overview
16.1.1 US FDA
16.1.2 EU EMA
16.1.5 Others
17 Supplier Landscape
17.1 Novo Nordisk A/S
17.1.1 Financial Analysis
17.1.2 Product Portfolio
17.1.3 Demographic Reach and Achievements
17.1.4 Mergers and Acquisitions
17.1.5 Certifications
17.2.1 Financial Analysis
17.2.2 Product Portfolio
17.2.3 Demographic Reach and Achievements
17.2.4 Mergers and Acquisitions
17.2.5 Certifications
17.3 B. Braun Melsungen AG
17.3.1 Financial Analysis
17.3.2 Product Portfolio
17.3.3 Demographic Reach and Achievements
17.3.4 Mergers and Acquisitions
17.3.5 Certifications
17.4.1 Financial Analysis
17.4.2 Product Portfolio
17.4.3 Demographic Reach and Achievements
17.4.4 Mergers and Acquisitions
17.4.5 Certifications
17.5 Terumo Corporation
17.5.1 Financial Analysis
17.5.2 Product Portfolio
17.5.3 Demographic Reach and Achievements
17.5.4 Mergers and Acquisitions
17.5.5 Certifications
17.6 BD
17.6.1 Financial Analysis
17.6.2 Product Portfolio
17.6.3 Demographic Reach and Achievements
17.6.4 Mergers and Acquisitions
17.6.5 Certifications
17.7 Owen Mumford Inc.
17.7.1 Financial Analysis
17.7.2 Product Portfolio
17.7.3 Demographic Reach and Achievements
17.7.4 Mergers and Acquisitions
17.7.5 Certifications
17.8 UltiMed, Inc.
17.8.1 Financial Analysis
17.8.2 Product Portfolio
17.8.3 Demographic Reach and Achievements
17.8.4 Mergers and Acquisitions
17.8.5 Certifications
17.9 Artsana S.p.A.
17.9.1 Financial Analysis
17.9.2 Product Portfolio
17.9.3 Demographic Reach and Achievements
17.9.4 Mergers and Acquisitions
17.9.5 Certifications
17.10 Trividia Health, Inc
17.10.1 Financial Analysis
17.10.2 Product Portfolio
17.10.3 Demographic Reach and Achievements
17.10.4 Mergers and Acquisitions
17.10.5 Certifications
17.11 STAT Medical Devices
17.11.1 Financial Analysis
17.11.2 Product Portfolio
17.11.3 Demographic Reach and Achievements
17.11.4 Mergers and Acquisitions
17.11.5 Certifications
17.12 Simple Diagnostics
17.12.1 Financial Analysis
17.12.2 Product Portfolio
17.12.3 Demographic Reach and Achievements
17.12.4 Mergers and Acquisitions
17.12.5 Certifications
17.13 Pietrasanta Pharma SpA
17.13.1 Financial Analysis
17.13.2 Product Portfolio
17.13.3 Demographic Reach and Achievements
17.13.4 Mergers and Acquisitions
17.13.5 Certifications
17.14 Henso Medical (Hangzhou) Co., Ltd.
17.14.1 Financial Analysis
17.14.2 Product Portfolio
17.14.3 Demographic Reach and Achievements
17.14.4 Mergers and Acquisitions
17.14.5 Certifications
17.15 Shanghai Beipu Medical Co., Ltd
17.15.1 Financial Analysis
17.15.2 Product Portfolio
17.15.3 Demographic Reach and Achievements
17.15.4 Mergers and Acquisitions
17.15.5 Certifications
17.16 Zhejiang Kindly Medical Devices Co., Ltd.
17.16.1 Financial Analysis
17.16.2 Product Portfolio
17.16.3 Demographic Reach and Achievements
17.16.4 Mergers and Acquisitions
17.16.5 Certifications
17.17 ARKRAY, Inc.
17.17.1 Financial Analysis
17.17.2 Product Portfolio
17.17.3 Demographic Reach and Achievements
17.17.4 Mergers and Acquisitions
17.17.5 Certifications
17.18 AstraZeneca
17.18.1 Financial Analysis
17.18.2 Product Portfolio
17.18.3 Demographic Reach and Achievements
17.18.4 Mergers and Acquisitions
17.18.5 Certifications
17.19 GlaxoSmithKline plc
17.19.1 Financial Analysis
17.19.2 Product Portfolio
17.19.3 Demographic Reach and Achievements
17.19.4 Mergers and Acquisitions
17.19.5 Certifications
18 Global Pen Needles Market - Distribution Model (Additional Insight)
18.1 Overview
18.2 Potential Distributors
18.3 Key Parameters for Distribution Partner Assessment
19 Key Opinion Leaders (KOL) Insights (Additional Insight)
20 Company Competitiveness Analysis (Additional Insight)
20.1 Very Small Companies
20.2 Small Companies
20.3 Mid-Sized Companies
20.4 Large Companies
20.5 Very Large Companies
21 Payment Methods (Additional Insight)
21.1 Government Funded
21.2 Private Insurance
21.3 Out-of-Pocket

Companies Mentioned

  • Novo Nordisk A/S
  • Ypsomed
  • B. Braun Melsungen AG
  • Htl-Strefa S.A.
  • Terumo Corporation
  • Bd
  • Owen Mumford Inc.
  • Ultimed, Inc.
  • Artsana S.P.A.
  • Trividia Health, Inc
  • Stat Medical Devices
  • Simple Diagnostics
  • Pietrasanta Pharma Spa
  • Henso Medical (Hangzhou) Co. Ltd.
  • Shanghai Beipu Medical Co. Ltd
  • Zhejiang Kindly Medical Devices Co. Ltd.
  • Arkray, Inc.
  • Astrazeneca
  • GlaxoSmithKline plc



Table Information